| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| 5-Bromo-4,7-diazaindole |
5-溴-4,7-二氮雜吲哚 |
875781-43-4 |
詳細(xì)
|
| Cabotegravir |
卡博特韋 |
1051375-10-0 |
詳細(xì)
|
| 4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione |
1-環(huán)丙基-4-異硫代氰?；?/td>
| 1533519-84-4 |
詳細(xì)
|
| 2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexene-1-carboxaldehyde |
2-(4-氯苯基)-4,4-二甲基-1-環(huán)己烯-1-甲醛 |
1228837-05-5 |
詳細(xì)
|
| 3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)benzenesulfonamide |
3-硝基-4-((四氫-2H-吡喃-4-基)甲基氨基)苯磺酰胺 |
1228779-96-1 |
詳細(xì)
|
| 1426129-50-1 enantioMer |
1426129-50-1對(duì)映異構(gòu)體 |
153037-40-2 |
詳細(xì)
|
| Treprostinil intermediate 2 |
(4S)-[4-[(四氫-2H-吡喃-2-基)氧基]壬基]膦酸二甲酯 |
101691-98-9 |
詳細(xì)
|
| (2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
(2S,4R)-5-(聯(lián)苯基-4-基)-4-[(叔丁氧羰基)氨基]-2-甲基戊酸 |
1012341-54-6 |
詳細(xì)
|
| ABT199 intermediates |
ABT199中間體 |
1235865-75-4 |
詳細(xì)
|
| Selonsertib |
司隆色替//瑟隆舍替 |
1448428-04-3 |
詳細(xì)
|
| 1,6-NAPHTHYRIDINE-3-CARBOXAMIDE, 4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-1,4-DIHYDRO-2,8-DIMETHYL-, (4R)- |
(R)-非奈利酮 |
1050477-30-9 |
詳細(xì)
|
| Pimodivir (VX-787) |
VX-787 |
1629869-44-8 |
詳細(xì)
|
| Ibrutinib |
依魯替尼 |
936563-96-1 |
詳細(xì)
|
| Rolapitant |
羅拉吡坦 |
552292-08-7 |
詳細(xì)
|
| Aprocitentan;ACT-132577 |
N-[5-(4-溴苯基)-6-[2-[(5-溴-2-嘧啶基)氧基]乙氧基]-4-嘧啶基]氨基磺酰胺 ；阿普昔騰坦//阿普洛騰坦 |
1103522-45-7 |
詳細(xì)
|
| 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine dihydrochloride |
4-((2-(4-氯苯基)-4,4-二甲基-1-環(huán)己烯)甲基)哌嗪二鹽酸鹽 |
1628047-87-9 |
詳細(xì)
|
| 4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide |
非奈利酮中間體 |
1050477-27-4 |
詳細(xì)
|
| N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide |
N-(吡啶-2-基)-4-(4,4,5,5-四甲基L-1,3,2-二氧硼戊環(huán)-2-基)本甲酰胺 |
1383385-64-5 |
詳細(xì)
|
| Upadacitinib intermediate2 |
烏帕替尼中間體2 |
1201187-44-1 |
詳細(xì)
|
| Abrocitinib |
PF-04965842(阿布羅替尼) |
1622902-68-4 |
詳細(xì)
|
| Valbenazine tosylate |
纈苯那嗪甲苯磺酸鹽 |
1639208-54-0 |
詳細(xì)
|
| (2Z,5Z)-5-(3-chloro-4-((R)-2,3-dihydroxypropoxy)benzylidene)-2-(propyliMino)-3-(o-tolyl)thiazolidin-4-one |
|
854107-55-4 |
詳細(xì)
|
| Talazoparib |
(8S,9R)-5-氟-8-(4-氟苯基)-2,7,8,9-四氫-9-(1-甲基-1H-1,2,4-三唑-5-基)-3H-吡啶并[4,3,2-de]酞嗪-3-酮 |
1207456-01-6 |
詳細(xì)
|
| Acalabrutinib |
阿卡替尼 |
1420477-60-6 |
詳細(xì)
|
| Relugolix intermediate1 |
瑞盧戈利中間體1 |
308831-93-8 |
詳細(xì)
|
| Relugolix intermediate4 |
瑞盧戈利中間體4 |
1589503-97-8 |
詳細(xì)
|
| (2-Fluoro-6-(trifluoromethyl)phenyl)methanamine hydrochloride |
2-氟-6-三氟甲基芐胺鹽酸鹽 |
643088-07-7 |
詳細(xì)
|
| Galeterone |
(3BETA)-17-(1H-苯并咪唑-1-基)雄甾-5,16-二烯-3-醇 |
851983-85-2 |
詳細(xì)
|
| N-[(1S)-3-Methyl-1-[[(2R)-2-Methyl-2-oxiranyl]carbonyl]butyl]-CarbaMic acid, 1,1-diMethylethyl ester |
boc-保護(hù)卡菲佐咪中間體,[(1S)-3-甲基-1-[[(2R)-2-甲基環(huán)氧乙基]羰基]丁基]氨基甲酸叔丁酯 |
247068-82-2 |
詳細(xì)
|
| 5-Biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methyl-pent-2-enoic acid |
(R)-5-([1,1'-聯(lián)苯]-4-基)-4-((叔丁氧羰基)氨基)-2-甲基-2-戊烯酸 |
1012341-48-8 |
詳細(xì)
|
| Methyl 2-[[4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetate |
2-[[4-(4-環(huán)丙基萘-1-基)-4H-1,2,4-三唑-3-基]硫基]乙酸甲酯 |
1533519-85-5 |
詳細(xì)
|
| 5-Hydroxy-7-azaindole |
5-羥基-7-氮雜吲哚 |
98549-88-3 |
詳細(xì)
|
| 1-(2-fluoro-6-(trifluoromethyl)benzyl)-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione |
1-((2-氟-6-(三氟甲基)苯基)甲基)-5-碘-6-甲基-2,4(1H,3H)-嘧啶二酮；惡拉戈利中間體 |
1150560-54-5 |
詳細(xì)
|
| 1-(2-Fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione |
1-[2-氟-6-(三氟甲基)芐基]-6-甲基嘧啶-2,4(1H,3H)-二酮 |
830346-47-9 |
詳細(xì)
|
| Gefapixant |
吉法匹生 |
1015787-98-0 |
詳細(xì)
|
| Relugolix |
瑞盧戈利 |
737789-87-6 |
詳細(xì)
|
| MGL-3196 |
MGL-3196 |
920509-32-6 |
詳細(xì)
|
| Lumicitabine |
化合物L(fēng)UMICITABINE |
1445385-02-3 |
詳細(xì)
|
| Vilaprisan |
Vistusertib |
1262108-14-4 |
詳細(xì)
|
| 2-Fluoro-3-Methoxyphenylboronic acid |
2-氟-3-甲氧基苯硼酸 |
352303-67-4 |
詳細(xì)
|
|
(3-Chloropyrazin-2-yl)MethanaMine hydrochloride |
(3-氯吡嗪-2-基)甲胺鹽酸 |
939412-86-9 |
詳細(xì)
|
| Filgotinib (GLPG0634) |
非戈替尼 |
1206161-97-8 |
詳細(xì)
|
| BMN 673 |
(8R,9S)-5-氟-8-(4-氟苯基)-2,7,8,9-四氫-9-(1-甲基-1H-1,2,4-三唑-5-基)-3H-吡啶并[4,3,2-DE]酞嗪-3-酮 |
1207456-00-5 |
詳細(xì)
|
| Rosiptor;AQX-1125 |
羅西普托 |
782487-28-9 |
詳細(xì)
|
| (2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester |
(S)-苯基 2-(8-氨基-1-溴咪唑[1,5-A]吡嗪-3-基)吡咯烷-1-羧酸酯 |
1420478-88-1 |
詳細(xì)
|
| Upadacitinib |
烏帕替尼(ABT-494) |
1310726-60-3 |
詳細(xì)
|
| (S)-1-Boc-3-hydroxypiperidine |
(S)-1-叔丁氧羰基-3-羥基哌啶 |
143900-44-1 |
詳細(xì)
|
| N-Tosyl-5-bromo-4,7-diazaindole |
N-甲苯磺酰基-5-溴-4,7-二氮雜吲哚 |
1201186-54-0 |
詳細(xì)
|
| Sacubitril |
沙庫(kù)巴曲 |
149709-62-6 |
詳細(xì)
|
| ABT-199 |
ABT-199 |
1257044-40-8 |
詳細(xì)
|
| (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid |
(2R,4S)-5-(聯(lián)苯-4-基)-4-[(叔丁氧基羰基)氨基]-2-甲基戊酸 |
1012341-50-2 |
詳細(xì)
|
| tert-butyl 4-((4'-chloro-5,5-diMethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)Methyl)piperazine-1-carboxylate |
4-((2-(4-氯苯基)-4,4-二甲基-1-環(huán)己烯)甲基)哌嗪-1-羧酸叔丁酯 |
1228780-71-9 |
詳細(xì)
|
| Daprodustat |
達(dá)普司他 |
960539-70-2 |
詳細(xì)
|
| 2-Fluoro-6-(trifluoromethyl)benzylamine |
2-氯-6-(三氟甲基)芐胺 |
239087-06-0 |
詳細(xì)
|
| Methyl 2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazin-1-yl]benzoate |
2-[(1H-吡咯并[2,3-B]吡啶-5-基)氧基]-4-[4-[[2-(4-氯苯基)-4,4-二甲基環(huán)己-1-烯基]甲基]哌嗪-1-基]苯甲酸甲酯 |
1235865-76-5 |
詳細(xì)
|
| (R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride |
依魯替尼中間體 |
1701403-10-2 |
詳細(xì)
|
| Baloxavir marboxil |
巴洛沙韋 |
1985606-14-1 |
詳細(xì)
|
| Risdiplam |
利司撲蘭 |
1825352-65-5 |
詳細(xì)
|
| 4-(Pyridin-2-yl)aminocarbonylphenylboronicacid |
4-(2-吡啶基氨甲?；?苯硼酸 |
850568-25-1 |
詳細(xì)
|
| 5-bromo-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione |
5-溴-1-(2-氟-6-(三氟甲基)芐基)-4-羥基-6-甲基嘧啶-2(1H)-酮 |
830346-48-0 |
詳細(xì)
|
| 5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine; |
IBRUTINIB中間體(N-2);IBRUTINIB中間體;3-(4-苯氧基苯基)-1H- 吡唑并[3,4-D]嘧啶-4-胺; |
330786-24-8 |
詳細(xì)
|
| AHU-377 (heMicalciuM salt) |
LCZ696中間體 |
1369773-39-6 |
詳細(xì)
|
| 3-(1-Biphenyl-4-ylMethyl-3-ethoxycarbonyl-1-butylcarbaMoyl)propionate-3'-Methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylMethyl)aMino)butyrate |
LCZ696 |
936623-90-4 |
詳細(xì)
|
| Benzonitrile, 5-[3-[(1S)-2,3-dihydro-1-[(2-hydroxyethyl)aMino]-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-(1-Methylethoxy)- (HCl salt) |
OZANIMOD |
1306760-85-9 |
詳細(xì)
|
| Lemborexant |
LEMBOREXANT |
1369764-02-2 |
詳細(xì)
|
| Finerenone |
非奈利酮 |
1050477-31-0 |
詳細(xì)
|
| Treprostinil intermediate 1；(4-Hydroxy-nonyl)-phosphonic acid dimethyl ester |
（4-羥基-壬基）-磷酸二甲酯 |
1593674-47-5 |
詳細(xì)
|
| Voxelotor ;GBT 440 |
沃塞洛托 |
1446321-46-5 |
詳細(xì)
|
| Valbenazine |
纈苯那嗪 |
1025504-45-3 |
詳細(xì)
|
| (S)-benzyl 2-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate |
(S)-芐基 2-(1-溴-8-氯咪唑并[1,5-A]吡嗪-3-基)吡咯烷-1-羧酸 |
1420478-87-0 |
詳細(xì)
|
| Vadadustat |
伐度司他 |
1000025-07-9 |
詳細(xì)
|
| Ethyl 2-amino-4-methyl-5-(4-nitro-phenyl)-thiophene-3-carboxylate |
2-氨基-4-甲基-5-(4-硝基苯基)-3-噻吩羧酸乙酯；Relugolix中間體 |
174072-89-0 |
詳細(xì)
|
| BMS-986165 |
BMS-986165 |
1609392-27-9 |
詳細(xì)
|
| brivaracetam |
布瓦西坦 |
357336-20-0 |
詳細(xì)
|
| (4-chloro-3-(4-ethoxybenzyl)phenyl)((3aS,5R,6S,6aS)-6-hydroxy- |
(4-氯-3-(4-乙氧基芐基)苯基)((3aS,5R,6S,6aS)-6-羥基-2,2-二甲基四氫呋喃并[2,3-d][1,3]二氧雜環(huán)戊烯-5-基）甲酮 |
1103738-30-2 |
詳細(xì)
|
| 4-cyclopropylnaphthalen-1-aMine hydrochloride |
1-環(huán)丙基-4-萘胺鹽酸鹽 |
1533519-92-4 |
詳細(xì)
|
| 1-[[2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazine |
1-[[2-(4-氯苯基)-4,4-二甲基環(huán)己-1-烯基]甲基]哌嗪 |
1228780-72-0 |
詳細(xì)
|
| Relugolix intermediate3 |
瑞盧戈利中間體3 |
308831-95-0 |
詳細(xì)
|
| SAGE-217 |
|
1632051-40-1 |
詳細(xì)
|
| ARN-509 |
阿帕魯胺 |
956104-40-8 |
詳細(xì)
|
| Elagolix sodium |
惡拉戈利 鈉鹽 |
832720-36-2 |
詳細(xì)
|
| (2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoate |
(2R,4S)-乙基 5-([1,1'-聯(lián)苯]-4-基)-4-氨基-2-甲基戊酸鹽酸鹽 |
149690-12-0 |
詳細(xì)
|
| 5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione |
5-(2-氟-3-甲氧基苯基)-1-[[2-氟-6-(三氟甲基)苯基]甲基]-6-甲基-2,4(1H,3H)-嘧啶二酮 |
1150560-59-0 |
詳細(xì)
|
| 1012341-48-8 enantioMer |
1012341-48-8對(duì)映異構(gòu)體 |
1015037-46-3 |
詳細(xì)
|
| Relugolix intermediate2 |
瑞盧戈利中間體2 |
308831-94-9 |
詳細(xì)
|
| Upadacitinib intermediate5 |
烏帕替尼中間體5 |
1428243-26-8 |
詳細(xì)
|
| (3R,4S)-1-((benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid Dicyclohexylamine Salt |
(3R,4S)-1- ((芐氧基)羰基)-4-乙基吡咯烷-3-羧酸二環(huán)己胺鹽 |
2095311-49-0 |
詳細(xì)
|
| Relugolix intermediate5 |
瑞盧戈利中間體5 |
1589503-95-6 |
詳細(xì)
|